Carson Wealth (CWM LLC)’s Caris Life Sciences CAI Stock Holding History
Bought
Maintained
Sold
Other funds holding CAI
JHWEPV
SSP
B
PC
VPM
Carson Wealth (CWM LLC)'s CAI Position: Q1 2026 in Review
Carson Wealth (CWM LLC) increased its Caris Life Sciences (CAI) stake by 395% in Q1 2026, buying an estimated $15.1K and bringing the position to 866 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4567.
Carson Wealth (CWM LLC) first reported a position in CAI in Q2 2025 and has held it in 4 quarters since. The position peaked at $24K in Q3 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.
- Carson Wealth (CWM LLC) held 866 shares of Caris Life Sciences worth $15.5K as of Q1 2026.
- Carson Wealth (CWM LLC) bought 691 Caris Life Sciences shares in Q1 2026, an estimated $15.1K.
- Caris Life Sciences made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4567 holding.
- Carson Wealth (CWM LLC) first reported a position in Caris Life Sciences in Q2 2025 and has held it in 4 quarters since.
- Carson Wealth (CWM LLC)'s Caris Life Sciences position peaked at $24K in Q3 2025.
- 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.